Investing in an Initial Public Offering (IPO) like Influx Healthtech Ltd. is an exciting opportunity, but the real thrill comes when you check whether you’ve been allotted shares. The Influx Healthtech IPO allotment is expected to be finalised on June 23, 2025. This comprehensive guide walks you through how to check the Influx Healthtech Ltd. IPO allotment status online, step by step, with additional details to ensure a smooth experience for all investors, including first-timers.
What is the Influx Healthtech IPO?
Influx Healthtech Ltd. was established in 2018. It is a fast-growing healthcare equipment manufacturer, including diagnostic devices, medical imaging systems, and wearable health tech. The company caters to hospitals, clinics, and individual consumers, with a strong focus on innovation and exports to over 20 countries.
Why Invest? IPOs like Influx Healthtech provide an opportunity to own shares in a promising company with potential for significant growth. The company reported revenue of ₹850.45 crores and a profit of ₹112.34 crores in 2024, reflecting robust financial performance.
Risks: IPOs carry market volatility, regulatory changes, or oversubscription leading to non-allotment. Always review the Red Herring Prospectus (RHP) or consult a certified financial advisor before investing.
What is an IPO Allotment?
An IPO is when a company, like Influx Healthtech Ltd., offers its shares to the public for the first time. Investors apply for shares by paying an amount, hoping to become shareholders. The allotment process determines who receives shares and how many. Due to oversubscription, where applications exceed available shares, retail investors often use a lottery system. Checking the allotment status reveals whether you’ve received shares and, if so, how many, similar to checking if you’ve won a raffle.
When is Influx Healthtech IPO Allotment Status Out?
The Influx Healthtech IPO subscription period ran from June 18 to June 20, 2025, with the allotment expected to be finalised on June 23, 2025. The MUFG Intime India Private Ltd. ( Link Intime) registrar manages the allocation process. Investors may receive an email or SMS from NSE, BSE, or the registrar once the status is available.
Influx Healthtech IPO Subscription Status
As of the end of the subscription period on June 20, 2025, the subscription status is as follows:
Investor Category
Subscription (Times)
Qualified Institutional Buyers (QIBs)
92.15x
Non-Institutional Investors (NIIs)
40.25x
Retail Individual Investors (RIIs)
4.10x
Total
38.67x
How to Check Influx Healthtech's IPO Allotment Status?
You can check the IPO allotment status on three primary platforms: the NSE website, the BSE website, or the registrar’s website (MUFG Intime). You’ll need one of the following details:
PAN Number: Your 10-digit Permanent Account Number.
Application Number: The unique number from your IPO application, found in your broker’s email/SMS or application form.
Demat Account Number (DP/Client ID): The ID of your demat account where shares will be credited.
If you don’t have these details, contact your broker or bank. Below are detailed steps for each platform, tailored for first-time users.
Checking Influx Healthtech IPO Allotment Status on NSE
The National Stock Exchange (NSE) provides a user-friendly platform to check allotment status. Here’s how:
Visit the NSE Website:
Open your phone or computer browser (e.g., Chrome, Safari).
Navigate to the IPO allotment section and select “Influx Healthtech Ltd.”
Enter your DP/Client ID to check if shares are credited.
Instructions for First-Time Users
If you’re new to IPOs, follow these tips to check allotment status easily:
Prepare Details in Advance: Write down your PAN, Application Number, and Demat ID in a note or save them on your phone.
Use a Familiar Device: Access the websites or apps on a device you’re comfortable with to avoid navigation issues.
Follow Step-by-Step Guides: Refer to the instructions above and proceed one step at a time.
Check Timelines: Allotment status is available only after June 23, 2025. Avoid checking too early to prevent confusion.
Ask for Guidance: If unsure, contact your broker or bank’s customer care for assistance.
Troubleshooting Common Issues
Website Not Loading:
Cause: High traffic on NSE, BSE, or MUFG Intime websites.
Solution: Try again after a few minutes, use a different platform, or check during off-peak hours (e.g., early morning).
IPO Not Listed in Dropdown:
Cause: Allotment may not be finalised yet.
Solution: Wait until June 23, 2025, or later, and check the IPO prospectus for updates.
Invalid PAN or Application Number:
Cause: Typographical errors or incorrect details.
Solution: Verify your details from your broker’s email/SMS or application form. Ensure you’re using the correct PAN linked to your Demat account.
No SMS/Email Received:
Cause: Delayed notifications or incorrect contact details.
Solution: Check directly on NSE, BSE, or MUFG Intime websites. Update your contact details with your broker for future IPOs.
App Not Working:
Cause: Outdated app or compatibility issues.
Solution: Update the app to the latest version or use the website instead.
Details on Refund Process
If you don’t receive shares, the blocked amount from your ASBA application will be unblocked. Here’s what to expect:
Timeline: Refunds are typically initiated on June 24, 2025, one day after allotment finalisation.
Process: The registrar (MUFG Intime) releases the blocked funds in your bank account. You’ll receive an SMS or email notification.
Delay in Refund: Contact your bank or the registrar if funds aren’t unblocked by June 25, 2025.
Use of Funds: Once unblocked, you can use the funds for other investments or future IPOs.
Tip: Check your bank account statement to confirm the unblocking of funds.
Information on Share Listing Process
Listing Date: Influx Healthtech shares are scheduled to list on BSE and NSE on June 25, 2025, at 10:00 AM IST.
Share Crediting: Allotted shares will be credited to your Demat account by June 24, 2025.
Trading: You can sell shares once trading begins on the listing day. Monitor the stock price on BSE/NSE apps or websites.
Grey Market Premium (GMP): As of June 20, 2025, the GMP is approximately ₹70, suggesting a listing price of ~₹684 (11.4% above the upper price band of ₹614). Note that GMP is unofficial and subject to change.
Contact Information for Support
MUFG Intime India Pvt. Ltd.:
Phone: +91-22-4918 6200
Email: influxhealthtech.ipo@linkintime.co.in
Address: C-101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai, Maharashtra 400083, India
NSE Investor Services:
Phone: +91-22-2659 8100
Email: ignse@nse.co.in
BSE Investor Services:
Phone: +91-22-2272 1233/34
Email: bsehelp@bseindia.com
Explanation of Oversubscription and Lottery Process
Oversubscription occurs when applications exceed available shares, as seen with Influx Healthtech’s 38.67x subscription. For retail investors (35% quota), only a fraction of applicants receive shares due to high demand.
Lottery Process: To ensure fairness, shares are allocated via a computerised lottery system for retail investors. For example, with a 4.10x subscription in the retail category, approximately 1 in 4 applicants may receive shares, depending on the lottery outcome.
Pro-rata Allocation: For NIIs and QIBs, shares may be allocated proportionally based on application size, with priority given to larger applications in some cases.
Clarification on ASBA Process
The Application Supported by Blocked Amount (ASBA) process is mandatory for IPO applications in India. Here’s how it works:
What is ASBA?:
Your application amount is blocked in your bank account rather than debited upfront. The funds remain in your account but are unavailable for other use until allotment.
How to Apply IPO using ASBA:
Use your bank’s net banking or UPI to apply through ASBA.
Select “Influx Healthtech IPO” in the IPO section, enter the number of lots (minimum 24 shares), and submit.
Approve the mandate in your banking app or net banking portal.
Post-Allotment: If allotted, the required amount is debited for the shares. If not, the blocked amount is released.
Tip: Ensure sufficient funds are available in your account during the subscription period (June 18–20, 2025).
Tax Implications
Capital Gains: If you sell allotted shares:
Short-Term Capital Gains (STCG): If sold within 12 months, gains are taxed at 15% (plus surcharge and cess).
Long-Term Capital Gains (LTCG): If held for over 12 months, gains above ₹1 lakh are taxed at 10% (plus surcharge/cess).
Losses: Losses can be set off against other capital gains, subject to tax rules.
Dividend Income: If Influx Healthtech declares dividends, they are taxable to shareholders according to their income tax slab.
Advice: Consult a tax professional like ClearTax to understand your tax obligations.
Post-Allotment Actions for Allotted Investors
If you receive shares:
Verify Demat Credit: Check your Demat account on June 24, 2025, to confirm share crediting.
Monitor Listing: Track the stock’s performance on BSE/NSE on June 25, 2025. Use apps like Moneycontrol or BSE/NSE websites.
Decide on Selling:
Short-Term: Sell on listing day for potential gains if the stock lists at a premium (GMP suggests ~₹684).
Long-Term: Hold if you believe in the company’s growth, given its strong financials and healthcare sector potential.
Set Stop-Loss: To manage risks, set a stop-loss order with your broker to limit potential losses if the stock price falls.
Conclusion
Checking the Influx Healthtech Ltd. IPO allotment status using the NSE, BSE, or MUFG Intime websites or apps is straightforward. Keep your PAN, Application Number, or Demat ID ready and check on or after June 23, 2025. If allotted shares, you’re now a part-owner of a promising healthcare technology company! If not, don’t be discouraged IPOs are on the horizon.
IPOs can be a wealth-building opportunity, but they come with risks. Always consult a certified financial advisor and review the company’s prospectus before investing. Happy investing, and good luck with your allotment!
Disclaimer: This article is for informational purposes only and not financial advice. IPO investments carry risks; you should read the company’s prospectus carefully and consult a certified financial advisor before making investment decisions.
I manifest my zeal in financial quantitative & quantitative research and have been instrumental in creating a robust process for the evaluation and monitoring of mutual funds. I’m responsible for Equity and Mutual Funds Research while creating instrumental mathematical models for portfolio construction after evaluating funds, and I play an integral role in analyzing changes in mutual funds, micro, and macro-economic indicators, and equity market events and trends. My views on asset classes which are integral in creating an investment strategy for any profile. Read more
Clear offers taxation & financial solutions to individuals, businesses, organizations & chartered accountants in India. Clear serves 1.5+ Million happy customers, 20000+ CAs & tax experts & 10000+ businesses across India.
Efiling Income Tax Returns(ITR) is made easy with Clear platform. Just upload your form 16, claim your deductions and get your acknowledgment number online. You can efile income tax return on your income from salary, house property, capital gains, business & profession and income from other sources. Further you can also file TDS returns, generate Form-16, use our Tax Calculator software, claim HRA, check refund status and generate rent receipts for Income Tax Filing.
CAs, experts and businesses can get GST ready with Clear GST software & certification course. Our GST Software helps CAs, tax experts & business to manage returns & invoices in an easy manner. Our Goods & Services Tax course includes tutorial videos, guides and expert assistance to help you in mastering Goods and Services Tax. Clear can also help you in getting your business registered for Goods & Services Tax Law.
Save taxes with Clear by investing in tax saving mutual funds (ELSS) online. Our experts suggest the best funds and you can get high returns by investing directly or through SIP. Download Black by ClearTax App to file returns from your mobile phone.
Cleartax is a product by Defmacro Software Pvt. Ltd.